Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 67457-925

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 67457-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

FDA Label Image

Carton 20s (Image 02)

Carton 20s (Image 02)
Dexmedetomidine HCI in 0.9% Sodium Chloride Injection is available in single-dose bottles with a 4 meg/mL or @ meg'/mL concentration for intravenous infusion. The bottles should be discarded if unused. The brand name of this medication is Mylan. There are two sizes available: 20 units x 50 mL and 50 mL. The dosage should be determined by a healthcare professional. The rest of the text is not-available or illegible.*
FDA Label Image

Carton 10s (Image 03)

Carton 10s (Image 03)
This is a drug information sheet for Dexmedetomidine HCI. It is available in an injection form for intravenous infusion in 0.9% Sodium Chloride. The strength available is 4 mcg/mL. The drug is manufactured by Mylan and is supplied in single-dose bottles. It is recommended to discard any unused portion.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.